UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000027390 |
|---|---|
| Receipt number | R000031392 |
| Scientific Title | A study for effects of 2-weeks consecutive suction of hydrogen to auto nervous system, central nervous system, immune system, inflammation and cognitive function in elderly people |
| Date of disclosure of the study information | 2017/05/21 |
| Last modified on | 2020/10/06 08:44:13 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
A study for effects of 2-weeks consecutive suction of hydrogen to auto nervous system, central nervous system, immune system, inflammation and cognitive function in elderly people
Acronym
A study for effects of 2-weeks consecutive suction of hydrogen in elderly people
Scientific Title
A study for effects of 2-weeks consecutive suction of hydrogen to auto nervous system, central nervous system, immune system, inflammation and cognitive function in elderly people
Scientific Title:Acronym
A study for effects of 2-weeks consecutive suction of hydrogen in elderly people
Region
| Japan |
Condition
Condition
Healthy adults
Classification by specialty
| Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To investigate the improving effects of 2-weeks consecutive suction of hydrogen to auto nervous system, central nervous system, immune system, inflammation and cognitive function in elderly people.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Evaluation of psychology, evaluation of function of auto nervous system and central nervous system.
Key secondary outcomes
Evaluation of immuno-ability, inflammation and cognitive function.
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Self control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Prevention
Type of intervention
| Other |
Interventions/Control_1
First visit: Testing after air suction, and then testing after hydrogen suction. At home: 5 times hydrogen suction in a day for 2 weeks. Second visit: Testing after air suction, and then testing after hydrogen suction.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 60 | years-old | <= |
Age-upper limit
| 74 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
1)Females aged 25 to 40 years old.
2)Subjects who show understanding of the clinical study procedures and agreement with participating the study by written informed consent prior to the study.
Key exclusion criteria
1)Subjects who have smoking habit.
2)Subjects who are cold-sensitive constitution.
3)Subjects who are receiving medical treatment of sleep, mental, immune.
4)Subjects who are currently receiving medication due to treatment of disease.
5)In the past month, subjects who have had custom of taking or applying medicine for the treatment of diseases.
6)Subjects who have previous and/or current medical history of serious disease in liver, kidney, heart, lung and/or blood.
7)Subjects with high blood pressure symptoms such as systolic blood pressure of 160 mmHg and more or diastolic blood pressure of 100 mmHg and more.
8)Subjects who have symptom of dermatologic disease such as atopic dermatitis.
9)Subjects who have undergone surgery on investigation objective portion within the past 6 months.
10)Subjects who are participating the other clinical tests of medicines or foods. Subjects who participated other clinical tests of medicines or foods within a month prior to the current study.
11)Subjects who themselves and/or their family are working for a company that develops, manufactures or sells health/functional foods and cosmetics.
12)Subjects who donated over 200mL blood and/or blood components within the last one month to the current study.
13)Males who donated over 400mL blood within the last three month to the current study.
14)Females who donated over 400mL blood within the last four month to the current study.
15)Males who will be collected over 1200mL blood, when the sampling amounts within the last twelve month are adding to the planned sampling amounts of this study.
16)Females who will be collected over 800mL blood, when the sampling amounts within the last twelve month are adding to the planned sampling amounts of this study.
17)Heavy alcohol drinker.
18)Others those have been determined ineligible by investigator.
Target sample size
20
Research contact person
Name of lead principal investigator
| 1st name | Suguru |
| Middle name | |
| Last name | Fujiwara |
Organization
CPCC Company Limited
Division name
Clinical Research Planning Department
Zip code
101-0047
Address
4F Chusin Building, 3-3-5 Uchikanda Chiyoda-ku, Tokyo 101-0047, JAPAN
TEL
03-5297-3112
cpcc-contact@cpcc.co.jp
Public contact
Name of contact person
| 1st name | Makoto |
| Middle name | |
| Last name | Ichinohe |
Organization
CPCC Company Limited
Division name
Planning & Sales Department
Zip code
101-0047
Address
4F Chusin Building, 3-3-5 Uchikanda Chiyoda-ku, Tokyo 101-0047, JAPAN
TEL
03-5297-3112
Homepage URL
cpcc-contact@cpcc.co.jp
Sponsor or person
Institute
CPCC Company Limited
Institute
Department
Personal name
Funding Source
Organization
P&C PLANNING CO., LTD.
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Institutional Review Board of Chiyoda Paramedical Care Clinic
Address
2F Chushin Building, 3-3-5 Uchikanda Chiyoda-ku, Tokyo 101-0047, Japan
Tel
03-5297-5548
IRB@cpcc.co.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2017 | Year | 05 | Month | 21 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2017 | Year | 04 | Month | 20 | Day |
Date of IRB
Anticipated trial start date
| 2017 | Year | 05 | Month | 22 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2017 | Year | 05 | Month | 18 | Day |
Last modified on
| 2020 | Year | 10 | Month | 06 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031392
| Research Plan | |
|---|---|
| Registered date | File name |
| Research case data specifications | |
|---|---|
| Registered date | File name |
| Research case data | |
|---|---|
| Registered date | File name |
